Cardiff Oncology (Germany) Market Value

XE7C Stock  EUR 5.33  0.00  0.00%   
Cardiff Oncology's market value is the price at which a share of Cardiff Oncology trades on a public exchange. It measures the collective expectations of Cardiff Oncology investors about its performance. Cardiff Oncology is trading at 1.36 as of the 28th of March 2024. This is a -24.52 percent down since the beginning of the trading day. The stock's lowest day price was 5.33.
With this module, you can estimate the performance of a buy and hold strategy of Cardiff Oncology and determine expected loss or profit from investing in Cardiff Oncology over a given investment horizon. Check out Cardiff Oncology Correlation, Cardiff Oncology Volatility and Cardiff Oncology Alpha and Beta module to complement your research on Cardiff Oncology.
For more detail on how to invest in Cardiff Stock please use our How to Invest in Cardiff Oncology guide.
Symbol

Please note, there is a significant difference between Cardiff Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardiff Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardiff Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Cardiff Oncology 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Cardiff Oncology's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Cardiff Oncology.
0.00
08/31/2023
No Change 0.00  0.0 
In 6 months and 30 days
03/28/2024
0.00
If you would invest  0.00  in Cardiff Oncology on August 31, 2023 and sell it all today you would earn a total of 0.00 from holding Cardiff Oncology or generate 0.0% return on investment in Cardiff Oncology over 210 days. Cardiff Oncology is related to or competes with GOODYEAR T, Compagnie Plastic, Applied Materials, US Physical, PETCO HEALTH, Yokohama Rubber, and CARDINAL HEALTH. Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer More

Cardiff Oncology Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Cardiff Oncology's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Cardiff Oncology upside and downside potential and time the market with a certain degree of confidence.

Cardiff Oncology Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Cardiff Oncology's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Cardiff Oncology's standard deviation. In reality, there are many statistical measures that can use Cardiff Oncology historical prices to predict the future Cardiff Oncology's volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cardiff Oncology's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.275.3314.72
Details
Intrinsic
Valuation
LowRealHigh
0.183.6313.02
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Cardiff Oncology. Your research has to be compared to or analyzed against Cardiff Oncology's peers to derive any actionable benefits. When done correctly, Cardiff Oncology's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Cardiff Oncology.

Cardiff Oncology Backtested Returns

Cardiff Oncology is dangerous given 3 months investment horizon. Cardiff Oncology secures Sharpe Ratio (or Efficiency) of 0.29, which signifies that the company had a 0.29% return per unit of risk over the last 3 months. We were able to analyze twenty-four different technical indicators, which can help you to evaluate if expected returns of 2.73% are justified by taking the suggested risk. Use Cardiff Oncology Risk Adjusted Performance of 0.1708, mean deviation of 6.19, and Downside Deviation of 5.26 to evaluate company specific risk that cannot be diversified away. Cardiff Oncology holds a performance score of 22 on a scale of zero to a hundred. The firm shows a Beta (market volatility) of -0.0439, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Cardiff Oncology are expected to decrease at a much lower rate. During the bear market, Cardiff Oncology is likely to outperform the market. Use Cardiff Oncology value at risk, downside variance, and the relationship between the maximum drawdown and potential upside , to analyze future returns on Cardiff Oncology.

Auto-correlation

    
  -0.31  

Poor reverse predictability

Cardiff Oncology has poor reverse predictability. Overlapping area represents the amount of predictability between Cardiff Oncology time series from 31st of August 2023 to 14th of December 2023 and 14th of December 2023 to 28th of March 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Cardiff Oncology price movement. The serial correlation of -0.31 indicates that nearly 31.0% of current Cardiff Oncology price fluctuation can be explain by its past prices.
Correlation Coefficient-0.31
Spearman Rank Test-0.68
Residual Average0.0
Price Variance1.49

Cardiff Oncology lagged returns against current returns

Autocorrelation, which is Cardiff Oncology stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Cardiff Oncology's stock expected returns. We can calculate the autocorrelation of Cardiff Oncology returns to help us make a trade decision. For example, suppose you find that Cardiff Oncology has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Cardiff Oncology regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Cardiff Oncology stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Cardiff Oncology stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Cardiff Oncology stock over time.
   Current vs Lagged Prices   
       Timeline  

Cardiff Oncology Lagged Returns

When evaluating Cardiff Oncology's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Cardiff Oncology stock have on its future price. Cardiff Oncology autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Cardiff Oncology autocorrelation shows the relationship between Cardiff Oncology stock current value and its past values and can show if there is a momentum factor associated with investing in Cardiff Oncology.
   Regressed Prices   
       Timeline  

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Cardiff Oncology in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Cardiff Oncology's short interest history, or implied volatility extrapolated from Cardiff Oncology options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Cardiff Oncology is a strong investment it is important to analyze Cardiff Oncology's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Cardiff Oncology's future performance. For an informed investment choice regarding Cardiff Stock, refer to the following important reports:
Check out Cardiff Oncology Correlation, Cardiff Oncology Volatility and Cardiff Oncology Alpha and Beta module to complement your research on Cardiff Oncology.
For more detail on how to invest in Cardiff Stock please use our How to Invest in Cardiff Oncology guide.
Note that the Cardiff Oncology information on this page should be used as a complementary analysis to other Cardiff Oncology's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Complementary Tools for Cardiff Stock analysis

When running Cardiff Oncology's price analysis, check to measure Cardiff Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardiff Oncology is operating at the current time. Most of Cardiff Oncology's value examination focuses on studying past and present price action to predict the probability of Cardiff Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardiff Oncology's price. Additionally, you may evaluate how the addition of Cardiff Oncology to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Commodity Directory
Find actively traded commodities issued by global exchanges
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Bonds Directory
Find actively traded corporate debentures issued by US companies
Cardiff Oncology technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Cardiff Oncology technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Cardiff Oncology trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...